Franklin Resources
ABUS icon

Franklin Resources’s Arbutus Biopharma ABUS Stock Holding History

Franklin Resources’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-104,423
Closed -$323K – 3129
2025
Q2 		$323K Buy
104,423
+11,984
+13% +$39.8K ﹤0.01% 2537
2025
Q1 		$323K Buy
92,439
+280
+0.3% +$934 ﹤0.01% 2450
2024
Q4 		$301K Buy
+92,159
New +$339K ﹤0.01% 2499
2023
Q2 		– Sell
-31,436
Closed -$95.3K – 2723
2023
Q1 		$95.3K Hold
31,436
– – ﹤0.01% 2113
2022
Q4 		$73.2K Sell
31,436
-115
-0.4% -$275 ﹤0.01% 2163
2022
Q3 		$60K Buy
31,551
+84
+0.3% +$198 ﹤0.01% 2177
2022
Q2 		$85K Sell
31,467
-14,433
-31% -$36.9K ﹤0.01% 2177
2022
Q1 		$137K Buy
+45,900
New +$141K ﹤0.01% 2237
2016
Q1 		– Sell
-1,287,560
Closed -$5.73M – 1508
2015
Q4 		$5.73M Sell
1,287,560
-768,740
-37% -$4.21M ﹤0.01% 1109
2015
Q3 		$12.5M Hold
2,056,300
– – 0.01% 961
2015
Q2 		$24.4M Buy
2,056,300
+71,400
+4% +$1.09M 0.01% 844
2015
Q1 		$34.7M Buy
1,984,900
+349,050
+21% +$7.15M 0.02% 728
2014
Q4 		$24.8M Buy
1,635,850
+589,750
+56% +$10.2M 0.01% 817
2014
Q3 		$22.1M Sell
1,046,100
-1,225,600
-54% -$20M 0.01% 843
2014
Q2 		$29.7M Buy
2,271,700
+100,100
+5% +$1.42M 0.01% 769
2014
Q1 		$46.7M Buy
2,171,600
+149,200
+7% +$2.68M 0.02% 602
2013
Q4 		$16.1M Buy
+2,022,400
New +$16.8M 0.01% 873

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources's ABUS Position: Q3 2025 in Review

Franklin Resources sold out of Arbutus Biopharma (ABUS) in Q3 2025, closing a stake of 104,423 shares — an estimated $323K sold.

Franklin Resources first reported a position in ABUS in Q4 2013 and held it in 17 quarters. The position peaked at $46.7M in Q1 2014. 166 funds tracked by Wall St. Rank hold ABUS as of Q3 2025.

  • Franklin Resources reported no remaining Arbutus Biopharma position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 104,423 Arbutus Biopharma shares in Q3 2025, an estimated $323K.
  • Franklin Resources first reported a position in Arbutus Biopharma in Q4 2013 and held it in 17 quarters.
  • Franklin Resources's Arbutus Biopharma position peaked at $46.7M in Q1 2014.
  • 166 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.